European Alliance for Personalised Medicine shared a post on LinkedIn:
“Building on Vision Europe
At the beginning of September, the Vision Europe 2030 Conference (2–3 September, Brussels ) brought together political leaders, experts, and stakeholders from across the continent for two days of in-depth discussions on the future of health innovation and policy. The conference provided a platform to address urgent challenges and opportunities, with a strong focus on collaboration, evidence-based policy, and actionable strategies that can shape a healthier future for Europe and beyond.
The conversations and commitments made in Brussels do not end there. Instead, they serve as the foundation for a global continuation of the dialogue.
This past week in New York, on the sidelines of UNGA High-Level Week, the journey advanced with the Last Mile series:
At the Italian Cultural Institute, stakeholders explored ‘Screening, Vaccination, and Treatment: Driving Investment, Innovation, and Alignment, highlighting why investment in innovation is essential to closing gaps in cancer and NCD care.
At the United Nations Headquarters, in a session co-hosted with the Permanent Mission of the Philippines, we gathered ministers, diplomats, experts, and patient advocates for ‘The Last Mile: Bridging the Cancer and NCD Innovation Gap’, focusing on early detection, AI, and equitable access.
We were also proud to welcome in New York many of the speakers who joined us in Brussels, including Josep Figueras, Hesham ElGhazaly, Pr Adda Bounedjar, Ruggero De Maria, Roberto Grasso, Zisis Kozlakidis and Lee-Anne Zinetti — ensuring continuity and amplifying the vision we began in Europe.
Together, these discussions are shaping a shared commitment to bring innovation closer to patients, strengthen partnerships, and build sustainable frameworks for health equity.”
More posts featuring European Alliance for Personalised Medicine.
